Success Stories: In Just 3 Days, Our Team Secured NIW Approval for a Senior Scientist and Writer/Researcher in the Field of Public Health from Nigeria

Client’s Testimonial:

“This is very fantastic! Very exciting news! I was thinking it will go through in about 45 days. The speed is beyond expectation. Thank you so much for the professional job well done. I am so glad to receive this so fast- within 3 days of receipt by USCIS. Very encouraging, indeed! Of a truth, it is a Congratulations to me.”

On August 14^th, 2023, we received another EB-2 NIW (National Interest Waiver) approval for a Senior Scientist and Writer/Researcher in the Field of Public Health (Approval Notice).

General Field: Public Health

Position at the Time of Case Filing: Senior Scientist and Writer/Researcher

Country of Origin: Nigeria

Country of Residence at the Time of Filing: United Kingdom

Approval Notice Date: August 14^th, 2023

Processing Time: 3 days (Premium Processing Requested)

Case Summary:

Our client reached out to the North America Immigration Law Group to handle the filing of his I-140 NIW (National Interest Waiver) petition. As a Ph.D. holder in public health, he provided copies of his transcripts, diploma, and degree certificate to verify his academic qualifications. After a thorough review of his credentials, we confirmed that he meets the eligibility criteria for working in professions requiring an advanced degree.

As an expert in the field of public health, his proposed endeavor is to continue his research on identifying and implementing proactive measures aimed at promoting health among healthcare workers and geriatric patients to improve quality of life and reduce the prevalence of communicable and non-communicable diseases.

Our client has made significant contributions to his field, having published 46 peer-reviewed journal articles (8 of them first-authored) in no fewer than 2 highly ranked peer-reviewed journals. His work was cited a total of 40 times, according to Google Scholar, thereby demonstrating that these publications are widely recognized and relied upon in the field of public health.

It should be noted that his research into preventing lifestyle/non-communicable diseases among sedentary health workers and unravelling the impact of a physical activity-promoting intervention program on musculoskeletal disorders among older adults will continue to be circulated to others in the field through the publication of papers in peer-reviewed journals and conferences.

Furthermore, he received two recommendation letters from esteemed experts affirming his strong research record and the significance of his contributions. One of the letters stated:

“[Client’s] critical work delves into the crucial challenges posed by the rising burden of noncommunicable diseases, such as obesity, diabetes, and heart disease. [Client’s] profound expertise and unique approach to bridging the gap between awareness and action in healthcare policies and practices set him apart in his field, making his continued work in the United States invaluable in advancing public health initiatives and combating the effects of non-communicable diseases for a healthier future.”

With strong documentary evidence and expert testimony supporting his case, our client successfully demonstrated that he is a professional holding an advanced degree. We are delighted to share that his NIW petition was approved just 3 days after submission, following an upgrade to premium processing.

We sincerely appreciate his cooperation throughout the process and are honored to have been part of this remarkable success story. We wish him the very best in all his future endeavors.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.